BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28882999)

  • 21. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 22. Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.
    Zhang Y; Young ED; Bill K; Belousov R; Peng T; Lazar AJ; Pollock RE; Simmons PJ; Lev D; Kolonin MG
    Stem Cell Res; 2013 Sep; 11(2):772-81. PubMed ID: 23770802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
    Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
    Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
    Zhang P; Bill K; Liu J; Young E; Peng T; Bolshakov S; Hoffman A; Song Y; Demicco EG; Terrada DL; Creighton CJ; Anderson ML; Lazar AJ; Calin GG; Pollock RE; Lev D
    Cancer Res; 2012 Apr; 72(7):1751-62. PubMed ID: 22350414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-665 promotes the progression of gastric adenocarcinoma via elevating FAK activation through targeting SOCS3 and is negatively regulated by lncRNA MEG3.
    Tang H; Long Q; Zhuang K; Yan Y; Han K; Guo H; Lu X
    J Cell Physiol; 2020 May; 235(5):4709-4719. PubMed ID: 31650535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
    Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B
    Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
    Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
    Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
    Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a.
    Alowayed N; Salker MS; Zeng N; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):815-26. PubMed ID: 27497669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
    Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
    Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling.
    Gao F; Wang FG; Liu RR; Xue F; Zhang J; Xu GQ; Bi JH; Meng Z; Huo R
    Int J Oncol; 2017 May; 50(5):1821-1831. PubMed ID: 28393235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition.
    Smith KB; Tran LM; Tam BM; Shurell EM; Li Y; Braas D; Tap WD; Christofk HR; Dry SM; Eilber FC; Wu H
    Am J Pathol; 2013 Apr; 182(4):1400-11. PubMed ID: 23416162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
    Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.
    Anuj ; Arivazhagan L; Venkatraman G; Rayala SK
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipogenesis induces growth inhibition of dedifferentiated liposarcoma.
    Kim YJ; Yu DB; Kim M; Choi YL
    Cancer Sci; 2019 Aug; 110(8):2676-2683. PubMed ID: 31069877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
    Crago AM; Singer S
    Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
    Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
    Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.